-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BBI-3000 in Breast Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.BBI-3000 in Breast CancerDrug Details:BBI-3000 is under development for the treatment of cutaneous T cell lymphoma...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BBI-355 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BBI-355 in Solid Tumor Drug Details: BBI-335 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Sofpironium Bromide in Axillary Hyperhidrosis
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDataÂ’s proprietary machine learning algorithms developed using over 10 years of historical data. Sofpironium Bromide in Axillary Hyperhidrosis Drug Details: Sofpironium bromide (Ecclock) is an anticholinergic agent....
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – JWP-1601 in Atopic Dermatitis (Atopic Eczema)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JWP-1601 in Atopic Dermatitis (Atopic Eczema) Drug Details: JWP-1601 is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ABBVCLS-7262 in Amyotrophic Lateral Sclerosis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.ABBVCLS-7262 in Amyotrophic Lateral Sclerosis Drug Details:ABBVCLS-7262 is under development for the treatment of amyotrophic lateral...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AST-001 in Renal Cell Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AST-001 in Renal Cell Carcinoma Drug Details: AST-001 is under development for treatment of brain...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – OTX-2002 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OTX-2002 in Solid Tumor Drug Details: OTX-2002 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Tipelukast in Hypertriglyceridemia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Tipelukast in Hypertriglyceridemia Drug Details: Tipelukast (KCA-757) is under development for the treatment of non-alcoholic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Gotistobart in Adenoid Cystic Carcinoma (ACC)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Gotistobart in Adenoid Cystic Carcinoma (ACC) Drug Details: ONC-392 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Autogene Cevumeran in Triple-Negative Breast Cancer (TNBC)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Autogene Cevumeran in Triple-Negative Breast Cancer (TNBC) Drug Details: Autogene cevumeran is under development for...
-
Product Insights
![]()
Archdiocese Warsaw/ BBI Dev – Lake Lanskie Hotel – Warmian-Masurian Voivodeship
Equip yourself with the essential tools needed to make informed and profitable decisions with our Archdiocese Warsaw/ BBI Dev - Lake Lanskie Hotel - Warmian-Masurian Voivodeship report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
![]()
Archdiocese Warsaw/ BBI Dev – Roma Mixed-Use Tower – Masovian Voivodeship
Equip yourself with the essential tools needed to make informed and profitable decisions with our Archdiocese Warsaw/ BBI Dev - Roma Mixed-Use Tower - Masovian Voivodeship report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
![]()
BBI Group/ Todd Corp – Balla Balla Infrastructure Facilities – Western Australia
Equip yourself with the essential tools needed to make informed and profitable decisions with our BBI Group/ Todd Corp - Balla Balla Infrastructure Facilities - Western Australia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
![]()
BBI Group – Balla Balla Vanadium-Titanium-Magnetite Processing Complex – Western Australia
Equip yourself with the essential tools needed to make informed and profitable decisions with our BBI Group - Balla Balla Vanadium-Titanium-Magnetite Processing Complex - Western Australia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Company Profile
![]()
Fresh Tracks Therapeutics Inc – Company Profile
Fresh Tracks Therapeutics Inc (Fresh Tracks Therapeutics) formerly Brickell Biotech Inc, discovers and develops pharmaceutical products for inflammatory, autoimmune and other debilitating diseases. The company is investigating BBI-02, an oral DYRK1A inhibitor to treat atopic dermatitis, rheumatoid arthritis and type 1 diabetes: BBI-03, a topical DYRK1A inhibitor targeting dermatological autoimmune diseases. It is also evaluating BBI-10, an orally available covalent STING inhibitor for inflammatory diseases and rare monogenic disorders. Brickell Bio develops is products based on its proprietary novel kinase...
Add to Basket -
Product Insights
![]()
Net Present Value Model: BBI-02
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model BBI-02 Drug Details FRTX-02Â is under development...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – BBI-3000
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry BBI-3000 Drug Details BBI-3000 is under development for the treatment of cutaneous T cell...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – BBI-001
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry BBI-001 Drug Details BBI-001 is under development for the treatment of hereditary hemochromatosis. The...
-
Product Insights
![]()
Net Present Value Model: Ecclock
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Ecclock Drug Details Sofpironium bromide (Ecclock)...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – sofpironium bromide
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry sofpironium bromide Drug Details Sofpironium bromide (Ecclock) is an anticholinergic agent. It is formulates...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.